JPM-Thematics-Gen.Therap.I2(acc)USD/ LU2112815027 /
NAV2024-04-25 | Chg.-2.4700 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
69.0600USD | -3.45% | reinvestment | Equity Worldwide | JPMorgan AM (EU) ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2020 | - | - | - | - | - | - | - | - | - | -3.14 | 16.42 | 9.32 | - |
2021 | 6.43 | -7.32 | -5.15 | 3.51 | -3.11 | 9.09 | -4.52 | 4.78 | -6.18 | -3.58 | -5.23 | -0.14 | -12.34% |
2022 | -17.81 | -2.50 | 3.06 | -11.16 | -6.94 | 2.47 | 8.98 | -0.18 | -5.76 | 1.32 | 1.81 | -4.34 | -29.21% |
2023 | 5.43 | -6.54 | -2.71 | 1.17 | 0.70 | -0.31 | 1.26 | -3.66 | -5.85 | -11.54 | 11.42 | 10.04 | -3.02% |
2024 | -0.98 | 8.61 | -2.83 | -13.21 | - | - | - | - | - | - | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 21.50% | 23.94% | 20.53% | 25.36% | -% |
Sharpe ratio | -1.43 | 0.45 | -0.74 | -0.84 | - |
Best month | +10.04% | +11.42% | +11.42% | +11.42% | - |
Worst month | -13.21% | -13.21% | -13.21% | -17.81% | - |
Maximum loss | -16.51% | -16.51% | -24.28% | -53.19% | - |
Outperformance | - | - | - | - | - |
All quotes in USD
Tranches
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
JPM-Thematics-Gen.Therap.I2(acc)... | reinvestment | 85.4400 | -11.41% | -44.49% | |
JPM-Thematics-Gen.Therap.C(acc)C... | reinvestment | 70.9500 | -13.34% | -46.45% | |
JPM-Thematics-Gen.Therap.A(acc)G... | reinvestment | 92.9500 | -10.71% | -43.28% | |
JPM-Thematics-Gen.Therap.A(acc)H... | reinvestment | 9.4500 | -10.68% | -42.55% | |
JPM-Thematics-Gen.Therap.A(acc)S... | reinvestment | 9.3200 | -11.58% | -43.27% | |
JPM-Thematics-Gen.Therap.A(dist)... | paying dividend | 92.9400 | -10.70% | -43.28% | |
JPM-Thematics-Gen.Therap.C(dist)... | paying dividend | 61.0800 | -11.92% | -37.36% | |
JPM-Thematics-Gen.Therap.C2(acc)... | reinvestment | 95.2000 | -10.23% | -42.37% | |
JPM-Thematics-Gen.Therap.C2(acc)... | reinvestment | 9.5500 | -11.16% | -42.37% | |
JPM-Thematics-Gen.Therap.C2(dist... | paying dividend | 94.8000 | -10.23% | -42.37% | |
JPM-Thematics-Gen.Therap.D(acc)E... | reinvestment | 71.0200 | -12.74% | -46.92% | |
JPM-Thematics-Gen.Therap.D(acc)U... | reinvestment | 63.3800 | -12.74% | -46.15% | |
JPM-Thematics-Gen.Therap.C2(acc)... | reinvestment | 86.8300 | -13.27% | -46.34% | |
JPM-Thematics-Gen.Therap.C2(acc)... | reinvestment | 90.2900 | -11.45% | -44.56% | |
JPM-Thematics-Gen.Therap.C2(acc)... | reinvestment | 94.3900 | -11.39% | -43.61% | |
JPM-Thematics-Gen.Therap.C2(dist... | paying dividend | 86.4900 | -13.27% | -46.34% | |
JPM-Thematics-Gen.Therap.C2(dist... | paying dividend | 89.8900 | -11.45% | -44.56% | |
JPM-Thematics-Gen.Therap.C2(dist... | paying dividend | 93.9700 | -11.39% | -43.62% | |
JPM-Thematics-Gen.Therap.I(acc)E... | reinvestment | 60.1900 | -11.49% | -44.62% | |
JPM-Thematics-Gen.Therap.I(acc)E... | reinvestment | 63.3400 | -8.93% | -36.47% | |
JPM-Thematics-Gen.Therap.I2(acc)... | reinvestment | 69.0600 | -11.36% | -43.56% | |
JPM-Thematics-Gen.Therap.C(acc)U... | reinvestment | 76.5800 | -11.45% | -43.73% | |
JPM-Thematics-Gen.Therap.C(acc)E... | reinvestment | 73.4900 | -11.51% | -44.67% | |
JPM-Thematics-Gen.Therap.C(dist)... | paying dividend | 55.1900 | -11.46% | -43.74% | |
JPM-Thematics-Gen.Therap.A(acc)U... | reinvestment | 92.4500 | -11.79% | -44.35% | |
JPM-Thematics-Gen.Therap.A(acc)E... | reinvestment | 88.4400 | -11.85% | -45.28% | |
JPM-Thematics-Gen.Therap.A(acc)C... | reinvestment | 84.7800 | -13.74% | -47.19% | |
JPM-Thematics-Gen.Therap.A(dist)... | paying dividend | 84.7500 | -13.74% | -47.19% | |
JPM-Thematics-Gen.Therap.A(dist)... | paying dividend | 88.1300 | -11.91% | -45.43% | |
JPM-Thematics-Gen.Therap.A(dist)... | paying dividend | 92.1200 | -11.86% | -44.51% |
Performance
YTD | -9.31% | ||
---|---|---|---|
6 Months | +7.09% | ||
1 Year | -11.36% | ||
3 Years | -43.56% | ||
5 Years | - | ||
Since start | -30.94% | ||
Year | |||
2023 | -3.02% | ||
2022 | -29.21% | ||
2021 | -12.34% |